Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler

Known as: tiotropium bromide 2.5 MCG / olodaterol 2.5 MCG per INHAL Metered Dose Inhaler, 60 ACTUAT, OLODATEROL 2.5MCG/TIOTROPIUM 2.5MCG/ACTUAT INHL,ORAL,60D,4GM [VA Product], OLODATEROL/TIOTROP 2.5MCG/ACTUAT 60D INH 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Chronic obstructive pulmonary disease is associated with significant morbidity and mortality. Trials of maintenance chronic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2016
Review
2016
Tiotropium–olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2016
2016
Purpose The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2015
Review
2015
  • Dtb Cmecpd
  • Drug and Therapeutics Bulletin
  • 2015
  • Corpus ID: 206924600
▼Olodaterol solution for inhalation (Striverdi Respimat—Boehringer Ingelheim) is a long-acting beta2 agonist (LABA) licensed for… Expand
Is this relevant?
2014
2014
Background Combining bronchodilators with different mechanisms of action may improve efficacy and reduce risk of side effects… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2014
2013
2013
Background The novel LABA olodaterol has 24-h bronchodilator activity. Objective To evaluate the symptomatic benefit of… Expand
Is this relevant?
2013
2013
Background: The novel LABA olodaterol (O) has an acceptable safety profile in clinical studies of ≤4 weeks (wks). Objective: To… Expand
Is this relevant?
2013
2013
fische Verteilung der Rezeptorsubtypen vorzuliegen, sondern vielmehr eine unterschiedliche Dichte der Rezeptorsubtypen in den… Expand
Is this relevant?
2011
2011
BACKGROUND Current guidelines recommend long-acting bronchodilators as maintenance therapy in COPD when symptoms are not… Expand
Is this relevant?